Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Aurélien Simona"'
Autor:
Wenyu Song, Max Lam, Ruize Liu, Aurélien Simona, Scott G. Weiner, Richard D. Urman, Kenneth J. Mukamal, Adam Wright, David W. Bates
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Opioid prescription records in existing electronic health record (EHR) databases are a potentially useful, high-fidelity data source for opioid use-related risk phenotyping in genetic analyses. Prescriptions for codeine derived from EHR reco
Externí odkaz:
https://doaj.org/article/dbd1f44fbf3d4eb8a178fda1a7c038e8
Publikováno v:
Frontiers in Genetics, Vol 14 (2023)
Pharmacogenomics (PGx) aims at tailoring drug therapy by considering patient genetic makeup. While drug dosage guidelines have been extensively based on single gene mutations (single nucleotide polymorphisms) over the last decade, polygenic risk scor
Externí odkaz:
https://doaj.org/article/d661660063b845058bd1dda68548ff24
Autor:
Ania Syrowatka, PhD, Wenyu Song, PhD, Mary G Amato, PharmD, Dinah Foer, MD, Heba Edrees, PharmD, Zoe Co, BS, Masha Kuznetsova, MPH, Sevan Dulgarian, BS, Diane L Seger, RPh, Aurélien Simona, MD, Paul A Bain, PhD, Gretchen Purcell Jackson, MD, Kyu Rhee, MD, David W Bates, ProfMD
Publikováno v:
The Lancet: Digital Health, Vol 4, Iss 2, Pp e137-e148 (2022)
Summary: Adverse drug events (ADEs) represent one of the most prevalent types of health-care-related harm, and there is substantial room for improvement in the way that they are currently predicted and detected. We conducted a scoping review to ident
Externí odkaz:
https://doaj.org/article/b4a56145798f4970a110fd2638bae3d2
Autor:
Nicolas Vuilleumier, Aurélien Simona, Marie Méan, Andreas Limacher, Pierre Lescuyer, Eric Gerstel, Henri Bounameaux, Drahomir Aujesky, Marc Righini
Publikováno v:
PLoS ONE, Vol 11, Iss 5, p e0155973 (2016)
UNLABELLED:Biomarkers unrelated to myocardial necrosis, such as cystatin C, copeptin, and mid-regional pro-adrenomedullin (MR-proADM), showed promise for cardiovascular risk prediction. Knowing whether they are comparable to cardiac biomarkers such a
Externí odkaz:
https://doaj.org/article/bb0568d213ed4fa681a1821295874f90
Publikováno v:
Drug Safety. 45:449-458
Pharmacovigilance improves patient safety by detecting and preventing adverse drug events. However, challenges exist that limit adverse drug event detection, resulting in many adverse drug events being underreported or inaccurately reported. One chal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44b664b858e8df496e76a770bb86c42d
https://doi.org/10.1007/s40264-022-01172-5
https://doi.org/10.1007/s40264-022-01172-5
Autor:
Marie Méan, Marc Philip Righini, Nicolas Vuilleumier, Aurélien Simona, Henri Bounameaux, Andreas Limacher, Drahomir Aujesky, Olivier Georges Golaz
Publikováno v:
Thrombosis Research, Vol. 185 (2019) pp. 5-12
Background Recent data have raised concerns about the risk/benefit ratio of thrombolysis in non-high risk pulmonary embolism patients due to increased serious bleeding events. Whether cardiac biomarkers could be of help for bleeding risk stratificati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b49965c3efd716f0a9dd3dd4cd930166
https://doi.org/10.1016/j.thromres.2019.11.006
https://doi.org/10.1016/j.thromres.2019.11.006
Autor:
Zoe Co, Paul A. Bain, David W. Bates, Gretchen Purcell Jackson, Wenyu Song, Masha Kuznetsova, Diane L. Seger, Ania Syrowatka, Mary G. Amato, Heba Edrees, Aurélien Simona, Kyu Rhee, Dinah Foer, Sevan M. Dulgarian
Publikováno v:
The Lancet: Digital Health, Vol 4, Iss 2, Pp e137-e148 (2022)
Summary: Adverse drug events (ADEs) represent one of the most prevalent types of health-care-related harm, and there is substantial room for improvement in the way that they are currently predicted and detected. We conducted a scoping review to ident
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e54df7669d29bc4fd8086acf488ea0a
https://pubmed.ncbi.nlm.nih.gov/34836823
https://pubmed.ncbi.nlm.nih.gov/34836823
Publikováno v:
American Journal of Medicine, Vol. 133, No 11 (2020) pp. 1249-1251
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f11aa4dac902152f8210b0ca3b74b950
https://pubmed.ncbi.nlm.nih.gov/32603792
https://pubmed.ncbi.nlm.nih.gov/32603792
Autor:
Estella S. Poloni, Jocelyne Chabert, Jules Alexandre Desmeules, Eva Kosek, Marie Besson, Valérie Piguet, Georg Ehret, Gisèle Pickering, Alain Matthey, Christine Cedraschi, Médéric Mouterde, Aurélien Simona, Yvonne Gloor, Luc Bovet
Publikováno v:
Drug Metabolism and Pharmacokinetics. 35:S81
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd76ca1130eec3f74becd622671cbdc7
https://doi.org/10.1016/j.dmpk.2020.04.193
https://doi.org/10.1016/j.dmpk.2020.04.193